Our full-service logistics and storage solutions help you seamlessly deliver innovation
Cell and gene therapy (CGT) logistics must overcome critical challenges that historically have affected the global cell therapy supply chain. Complex cell therapy logistics require precise temperature control and time-sensitive delivery. Explore how World Courier's cutting-edge solutions streamline these processes to ensure the safe and efficient transport of these groundbreaking therapies. Discover how we are revolutionizing the CGT supply chain as an advanced therapy logistics provider. Learn more about our comprehensive services and global expertise:
- An introduction to CGT
- CGT logistics solutions
- CGT supply chain challenges
- The World Courier difference
What is cell and gene therapy – and how does the supply chain work?
Cell and gene therapies (CGTs) represent the leading edge of biomedical research. Autologous and allogeneic cell, gene, and tissue therapies are transforming healthcare. Approvals of autologous CAR-T therapies such as Kymriah, Tecartus, and Yescarta and allogeneic treatments including Rethymic and Alofisel reinforce the advancements in this space.
CGT sponsors must consider every aspect of their development and manufacturing journey as early as possible to ensure their discovery therapy can be approved and commercialized without delay.
Planning for all stages of cell therapy logistics — including development, clinical trials, and commercialization — is a crucial part of this process. However, CGTs come with unique logistic requirements that add complexity and risk to their supply chains. Understanding the end-to-end supply chain of CGTs early ensures risks are mitigated before they cause delays in getting treatment to patients. Key aspects of a robust cold supply chain:
- Global real-time temperature and location monitoring
- 24/7 support
- Compliance support for import/export requirements special handling requirements
- Cryogenic packaging, storage, and transportation
Providing cell and gene therapy logistics solutions
Supporting advanced therapy solutions
Temperature-controlled solutions
Quality systems
Rising to the cell and gene therapy supply chain challenge
Global cryogenic charging locations
To support the growth of the advanced therapy solutions industry and enable more patients than ever before to be treated with these life-changing therapies, World Courier can charge across its network of more than 120+ offices globally.
Through this global network, we help advanced therapy companies build robust logistics platforms that support the clinical development and commercialization of therapies to meet patient treatment needs.
Solutions that grow with your needs
World Courier difference
Working with our partners
Why choose World Courier?
World Courier has specialist expertise in cell and gene therapy logistics. We are proud of our ability to collaborate with diverse organizations across the globe. These key attributes ensure the safe transport of critical medical supplies to those who need them most.
We recognize that in pharmaceutical logistics there is no room for error. Each shipment is handled with the utmost care. Our meticulous planning ensures that shipments arrive at their destination in optimal condition. Safeguarding patient health is our commitment.
Our team is made up of individuals with a high-level understanding of the pharma and healthcare industries. Their expertise enables them to offer innovative solutions so pharmaceutical integrity is preserved. With cold chain packaging materials to support shipments, we have got you covered.
Global LN2 charging capability
Our pharmaceutical delivery credentials
World Courier is a trusted provider of cell therapy supply chain management and pharmaceutical delivery services.
We prioritize quality and go beyond compliance to optimize the cell therapy supply chain. Our teams ensure regulatory compliance and mitigate risks through training and communication. By engaging stakeholders on a shipment-by-shipment basis, we deliver quality that exceeds minimum requirements. Trust us for secure and compliancy throughout your commercialization journey.
Other international guidelines we adhere to:
- GDP compliant
- National and State Board of Pharmacy licensed (where applicable)
- WHO good Distribution practices for pharmaceutical products, TRS No. 957 Annex 5
- EU Guidelines on good distribution practice of medicinal products for human use (2013/C 343/01)
- USP <1079> Good Storage and Shipping Practices for Drug Products, US Pharmacopeia
- Code of Federal Regulations (CFR) 21 Part 11 compliant
Cell and gene therapy FAQs
Are CGTs dangerous goods?
How do you ensure CGTs stay within the right temperature range?
How have cell and gene therapies evolved?
Why are CGTs so crucial today?
Cell and gene therapies are crucial because they offer a cutting edge approach to treating diseases. They offer personalized treatments for conditions like cancer and genetic disorders, holding the potential to revolutionize healthcare. With fewer side effects and the ability to address the causes of illnesses, these therapies offer new hope for patients who had limited options in the past, providing a path towards better outcomes and improved quality of life.
